BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
IGF1
,
G-protein-coupled receptor binding
,
Arthritis
,
Heart
,
Rapamycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
IRAK4
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Leukocyte (polymorphonuclear) of peripheral blood
Eosinophil of peripheral blood
Neutrophil of bone marrow
Mononuclear cell of peripheral blood
Basophil of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Streptococcal infectious disease
Barrett's esophagus
Microbial culture finding
Pyloric ulcer
Esophagitis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Ornithogalum glycoside
Debrisoquin
Benzydamine
MCI 186
isochlorogenic acid
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MOV10L1
KLF11
DCR
ADCY3
IMPA1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
A small molecule potent IRAK4 inhibitor abrogates lipopolysaccharide-induced macrophage inflammation…
Hypothalamic Irak4 is a genetically controlled regulator of hypoglycemia-induced glucagon secretion.
Interleukin-1 receptor-associated kinase 4 (IRAK4) in the nucleus accumbens regulates opioid-seeking…
USP13-mediated IRAK4 deubiquitination disrupts the pathological symptoms of lipopolysaccharides-indu…
Pharmacological inhibition of IRAK1 and IRAK4 prevents endothelial inflammation and atherosclerosis …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC)
Evaluation of Cutaneous and Circulating Inflammatory Biomarkers in Hidradenitis Suppurativa and Atop…
IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflam…
A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With A…
Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune Sy…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ